{"name":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","slug":"fundaci-n-p-blica-andaluza-para-la-gesti-n-de-la-investigaci-n-en-sevilla","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":7,"colorKey":"immunology","drugs":[{"name":"Empirical antimicrobial treatment discontinuation","genericName":"Empirical antimicrobial treatment discontinuation","slug":"empirical-antimicrobial-treatment-discontinuation","indication":"Other","status":"marketed"},{"name":"Any prophylaxis for GVHD","genericName":"Any prophylaxis for GVHD","slug":"any-prophylaxis-for-gvhd","indication":"Other","status":"phase_1"},{"name":"Fludeoxyglucose 18F","genericName":"Fludeoxyglucose 18F","slug":"fludeoxyglucose-18f","indication":"Other","status":"marketed"},{"name":"High doses of Thiamine y Biotin","genericName":"High doses of Thiamine y Biotin","slug":"high-doses-of-thiamine-y-biotin","indication":"Other","status":"phase_2"},{"name":"PEG-3350 with electrolytes","genericName":"PEG-3350 with electrolytes","slug":"peg-3350-with-electrolytes","indication":"Other","status":"marketed"},{"name":"Polyethylene Glycol 4000 with electrolytes","genericName":"Polyethylene Glycol 4000 with electrolytes","slug":"polyethylene-glycol-4000-with-electrolytes","indication":"Constipation","status":"marketed"},{"name":"Usual Antipsychotic Treatment","genericName":"Usual Antipsychotic Treatment","slug":"usual-antipsychotic-treatment","indication":"Other","status":"phase_2"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"oncology","drugs":[{"name":"Standard empirical antimicrobial treatment discontinuation","genericName":"Standard empirical antimicrobial treatment discontinuation","slug":"standard-empirical-antimicrobial-treatment-discontinuation","indication":"De-escalation of empirical antimicrobial therapy in hospitalized patients with suspected or confirmed infections","status":"marketed"},{"name":"Antipseudomonal beta-lactam antibiotic","genericName":"Antipseudomonal beta-lactam antibiotic","slug":"antipseudomonal-beta-lactam-antibiotic","indication":"Pseudomonas aeruginosa infections (respiratory, urinary, wound, bloodstream)","status":"phase_3"},{"name":"Ceftriaxone intravenous","genericName":"Ceftriaxone intravenous","slug":"ceftriaxone-intravenous","indication":"Bacterial infections (meningitis, pneumonia, gonorrhea, Lyme disease, sepsis)","status":"phase_3"},{"name":"Fosfomycin sodium intravenous","genericName":"Fosfomycin sodium intravenous","slug":"fosfomycin-sodium-intravenous","indication":"Serious bacterial infections caused by susceptible pathogens","status":"phase_3"},{"name":"Meropenem intravenous","genericName":"Meropenem intravenous","slug":"meropenem-intravenous","indication":"Serious bacterial infections (meningitis, intra-abdominal infections, pneumonia, sepsis)","status":"phase_3"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"romiplostim plus dexamethasone","genericName":"romiplostim plus dexamethasone","slug":"romiplostim-plus-dexamethasone","indication":"Immune thrombocytopenia (ITP)","status":"phase_3"}]}],"pipeline":[{"name":"Standard empirical antimicrobial treatment discontinuation","genericName":"Standard empirical antimicrobial treatment discontinuation","slug":"standard-empirical-antimicrobial-treatment-discontinuation","phase":"marketed","mechanism":"This is a clinical protocol for discontinuing empirical broad-spectrum antimicrobial therapy based on standardized criteria rather than a pharmacological drug.","indications":["De-escalation of empirical antimicrobial therapy in hospitalized patients with suspected or confirmed infections"],"catalyst":""},{"name":"Empirical antimicrobial treatment discontinuation","genericName":"Empirical antimicrobial treatment discontinuation","slug":"empirical-antimicrobial-treatment-discontinuation","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Antipseudomonal beta-lactam antibiotic","genericName":"Antipseudomonal beta-lactam antibiotic","slug":"antipseudomonal-beta-lactam-antibiotic","phase":"phase_3","mechanism":"Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to cell wall rupture and bacterial death, with activity against Pseudomonas aeruginosa and other gram-negative organisms.","indications":["Pseudomonas aeruginosa infections (respiratory, urinary, wound, bloodstream)","Nosocomial/hospital-acquired infections caused by gram-negative organisms"],"catalyst":""},{"name":"Any prophylaxis for GVHD","genericName":"Any prophylaxis for GVHD","slug":"any-prophylaxis-for-gvhd","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Ceftriaxone intravenous","genericName":"Ceftriaxone intravenous","slug":"ceftriaxone-intravenous","phase":"phase_3","mechanism":"Ceftriaxone inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins and blocking cross-linking of peptidoglycan.","indications":["Bacterial infections (meningitis, pneumonia, gonorrhea, Lyme disease, sepsis)","Surgical prophylaxis"],"catalyst":""},{"name":"Fludeoxyglucose 18F","genericName":"Fludeoxyglucose 18F","slug":"fludeoxyglucose-18f","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Fosfomycin sodium intravenous","genericName":"Fosfomycin sodium intravenous","slug":"fosfomycin-sodium-intravenous","phase":"phase_3","mechanism":"Fosfomycin inhibits bacterial cell wall synthesis by inactivating the MurA enzyme, preventing peptidoglycan cross-linking.","indications":["Serious bacterial infections caused by susceptible pathogens","Multidrug-resistant gram-negative infections"],"catalyst":""},{"name":"High doses of Thiamine y Biotin","genericName":"High doses of Thiamine y Biotin","slug":"high-doses-of-thiamine-y-biotin","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Meropenem intravenous","genericName":"Meropenem intravenous","slug":"meropenem-intravenous","phase":"phase_3","mechanism":"Meropenem is a broad-spectrum beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins.","indications":["Serious bacterial infections (meningitis, intra-abdominal infections, pneumonia, sepsis)","Hospital-acquired and community-acquired infections caused by susceptible organisms"],"catalyst":""},{"name":"PEG-3350 with electrolytes","genericName":"PEG-3350 with electrolytes","slug":"peg-3350-with-electrolytes","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Polyethylene Glycol 4000 with electrolytes","genericName":"Polyethylene Glycol 4000 with electrolytes","slug":"polyethylene-glycol-4000-with-electrolytes","phase":"marketed","mechanism":"Polyethylene glycol 4000 with electrolytes acts as an osmotic laxative that draws water into the bowel lumen while the electrolytes maintain fluid and electrolyte balance.","indications":["Constipation","Bowel preparation prior to colonoscopy or other gastrointestinal procedures"],"catalyst":""},{"name":"Usual Antipsychotic Treatment","genericName":"Usual Antipsychotic Treatment","slug":"usual-antipsychotic-treatment","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"romiplostim plus dexamethasone","genericName":"romiplostim plus dexamethasone","slug":"romiplostim-plus-dexamethasone","phase":"phase_3","mechanism":"Romiplostim stimulates thrombopoietin receptors to increase platelet production, while dexamethasone provides immunosuppressive and anti-inflammatory effects to treat immune thrombocytopenia.","indications":["Immune thrombocytopenia (ITP)"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":13,"phaseCounts":{"marketed":5,"phase_3":5,"phase_1":1,"phase_2":2},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}